- Home
- NAZ vs SGMO Comparison
NAZ vs SGMO Comparison
Compare NAZ & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAZ
- SGMO
- Stock Information
- Founded
- NAZ 1992
- SGMO 1995
- Country
- NAZ United States
- SGMO United States
- Employees
- NAZ N/A
- SGMO N/A
- Industry
- NAZ Finance/Investors Services
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NAZ Finance
- SGMO Health Care
- Exchange
- NAZ Nasdaq
- SGMO Nasdaq
- Market Cap
- NAZ 137.5M
- SGMO 122.8M
- IPO Year
- NAZ N/A
- SGMO 2000
- Fundamental
- Price
- NAZ $11.71
- SGMO $0.51
- Analyst Decision
- NAZ
- SGMO Strong Buy
- Analyst Count
- NAZ 0
- SGMO 7
- Target Price
- NAZ N/A
- SGMO $5.29
- AVG Volume (30 Days)
- NAZ 18.3K
- SGMO 4.1M
- Earning Date
- NAZ 01-01-0001
- SGMO 11-11-2025
- Dividend Yield
- NAZ 3.69%
- SGMO N/A
- EPS Growth
- NAZ N/A
- SGMO N/A
- EPS
- NAZ N/A
- SGMO N/A
- Revenue
- NAZ N/A
- SGMO $81,706,000.00
- Revenue This Year
- NAZ N/A
- SGMO $21.24
- Revenue Next Year
- NAZ N/A
- SGMO N/A
- P/E Ratio
- NAZ N/A
- SGMO N/A
- Revenue Growth
- NAZ N/A
- SGMO 565.52
- 52 Week Low
- NAZ $9.22
- SGMO $0.41
- 52 Week High
- NAZ $11.37
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- NAZ 44.66
- SGMO 45.86
- Support Level
- NAZ $11.63
- SGMO $0.49
- Resistance Level
- NAZ $11.99
- SGMO $0.56
- Average True Range (ATR)
- NAZ 0.10
- SGMO 0.03
- MACD
- NAZ -0.02
- SGMO -0.00
- Stochastic Oscillator
- NAZ 24.32
- SGMO 47.44
About NAZ Nuveen Arizona Quality Municipal Income Fund
Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to provide current income exempt from both regular federal income taxes and Arizona individual income taxes. The fund's secondary objective is to enhance the portfolio value relative to the Arizona municipal bond market through investments in tax-exempt Arizona Municipal Obligations that, in the opinion of the Fund's investment adviser, are underrated or undervalued or represent municipal market sectors that are undervalued.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.